SmartExpert

(118)

$30/per page/Negotiable

About SmartExpert

Levels Tought:
Elementary,Middle School,High School,College,University,PHD

Expertise:
Accounting,Business & Finance See all
Accounting,Business & Finance,Economics,English,HR Management,Math Hide all
Teaching Since: Apr 2017
Last Sign in: 56 Weeks Ago, 5 Days Ago
Questions Answered: 7570
Tutorials Posted: 7352

Education

  • BS,MBA, PHD
    Adelphi University/Devry
    Apr-2000 - Mar-2005

Experience

  • HOD ,Professor
    Adelphi University
    Sep-2007 - Apr-2017

Category > Health & Medical Posted 24 Sep 2019 My Price 5.00

HSA 535 Week 3 Discussion Sudden Infant Death Syndrome (SIDS)

"Sudden Infant Death Syndrome (SIDS)"  Please respond to the following:

·         From the first e-Activity, evaluate the concepts of incidence and prevalence in relation to SIDS in children.

·         From the second e-Activity, analyze and report on the morbidity and mortality rates of SIDS in your home state. Based on your analysis, give your thoughts on your findings.

"Morbidity, Mortality, and Associated Costs"  Please respond to the following:

·         From the third e-Activity, suggest at least three (3) financial management techniques that may be used to deal with the cost of addressing women’s health.

·         Based on the financial analysis techniques, suggest a cost-effective plan that might use this information to track women’s morbidity and mortality trends in your home state.

Answers

(118)
Status NEW Posted 24 Sep 2019 04:09 AM My Price 5.00

HSA----------- 53-----------5 W-----------eek----------- 3 -----------Dis-----------cus-----------sio-----------n S-----------udd-----------en -----------Inf-----------ant----------- De-----------ath----------- Sy-----------ndr-----------ome----------- (S-----------IDS-----------)-----------

Attachments

file 1569299398-HSA 535 Week 3 Discussion.docx preview (680 words )
H-----------SA -----------535----------- We-----------ek -----------3 D-----------isc-----------uss-----------ion----------- &-----------quo-----------t;S-----------udd-----------en -----------Inf-----------ant----------- De-----------ath----------- Sy-----------ndr-----------ome----------- (S-----------IDS-----------)&q-----------uot-----------; ----------- P-----------lea-----------se -----------res-----------pon-----------d t-----------o t-----------he -----------fol-----------low-----------ing-----------: -----------Fro-----------m t-----------he -----------fir-----------st -----------e-A-----------cti-----------vit-----------y, -----------eva-----------lua-----------te -----------the----------- co-----------nce-----------pts----------- of----------- in-----------cid-----------enc-----------e a-----------nd -----------pre-----------val-----------enc-----------e i-----------n r-----------ela-----------tio-----------n t-----------o S-----------IDS----------- in----------- ch-----------ild-----------ren-----------. -----------Fro-----------m t-----------he -----------sec-----------ond----------- e------------Act-----------ivi-----------ty,----------- an-----------aly-----------ze -----------and----------- re-----------por-----------t o-----------n t-----------he -----------mor-----------bid-----------ity----------- an-----------d m-----------ort-----------ali-----------ty -----------rat-----------es -----------of -----------SID-----------S i-----------n y-----------our----------- ho-----------me -----------sta-----------te.----------- Ba-----------sed----------- on----------- yo-----------ur -----------ana-----------lys-----------is,----------- gi-----------ve -----------you-----------r t-----------hou-----------ght-----------s o-----------n y-----------our----------- fi-----------ndi-----------ngs-----------. -----------&qu-----------ot;-----------Mor-----------bid-----------ity-----------, M-----------ort-----------ali-----------ty,----------- an-----------d A-----------sso-----------cia-----------ted-----------
Not Rated(0)